Literature DB >> 23417699

Should we remove splenic hilus lymph nodes for esophagogastric junction adenocarcinoma?

H H Hartgrink1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23417699     DOI： 10.1007/s10120-013-0237-y

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  17 in total

1.  Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma.

Authors:  Y Kodera; Y Yamamura; Y Shimizu; A Torii; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  World J Surg       Date:  1997 Jul-Aug       Impact factor: 3.352

2.  New method to evaluate the therapeutic value of lymph node dissection for gastric cancer.

Authors:  M Sasako; P McCulloch; T Kinoshita; K Maruyama
Journal:  Br J Surg       Date:  1995-03       Impact factor: 6.939

Review 3.  A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer.

Authors:  Savtaj S Brar; Rajini Seevaratnam; Roberta Cardoso; Calvin Law; Lucy Helyer; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-09-14       Impact factor: 7.370

4.  Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer.

Authors:  Shinsuke Sasada; Motoki Ninomiya; Masahiko Nishizaki; Masao Harano; Yasutomo Ojima; Hiroyoshi Matsukawa; Hideki Aoki; Shigehiro Shiozaki; Satoshi Ohno; Norohisa Takakura
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

5.  Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients.

Authors:  G H Kampschöer; K Maruyama; C J van de Velde; M Sasako; T Kinoshita; K Okabayashi
Journal:  Br J Surg       Date:  1989-09       Impact factor: 6.939

6.  Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.

Authors:  Hiroharu Yamashita; Hitoshi Katai; Shinji Morita; Makoto Saka; Hirokazu Taniguchi; Takeo Fukagawa
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

7.  A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma.

Authors:  Attila Csendes; Patricio Burdiles; Jorge Rojas; Italo Braghetto; Juan Carlos Diaz; Fernando Maluenda
Journal:  Surgery       Date:  2002-04       Impact factor: 3.982

8.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

9.  Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.

Authors:  Suk Hee Shin; Hun Jung; Seong Hee Choi; Ji Yeong An; Min Gew Choi; Jae Hyung Noh; Tae Sung Sohn; Jae Moon Bae; Sung Kim
Journal:  Ann Surg Oncol       Date:  2009-02-25       Impact factor: 5.344

10.  Effect of microscopic resection line disease on gastric cancer survival.

Authors:  S H Kim; M S Karpeh; D S Klimstra; D Leung; M F Brennan
Journal:  J Gastrointest Surg       Date:  1999 Jan-Feb       Impact factor: 3.267
View more
  2 in total

1.  Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.

Authors:  Chen-Bin Lv; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

2.  Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction.

Authors:  Ming-Zhi Cai; Chen-Bin Lv; Li-Sheng Cai; Qiu-Xian Chen
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.